BRAF inhibitor dabrafenib in patients with metastatic BRAF-mutant thyroid cancer

G. Falchook, Michael Millward, D. Hong, A. Naing, S.A. Piha-Paul, S.G. Waguespack, M.E. Cabanillas, S.I. Sherman, B. Ma, M. Curtis, V.L. Goodman, R. Kurzrock

    Research output: Contribution to journalArticlepeer-review

    186 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'BRAF inhibitor dabrafenib in patients with metastatic BRAF-mutant thyroid cancer'. Together they form a unique fingerprint.

    Pharmacology, Toxicology and Pharmaceutical Science